In a recent investigation, scientists scrutinized the genetic composition of 250...
Bristol Myers Squibb (BMS) has disclosed a significant infusion of $400 million ...
Amidst the concerning rise of drug-resistant strains of gonorrhea, a recent brea...
Rapt Therapeutics faces a daunting challenge as the U.S. Food and Drug Administr...
The European Commission has granted its approval to Pfizer’s Velsipity for the t...
The Food and Drug Administration (FDA) has granted approval to AstraZeneca’s Tag...
The emergence of T-cell therapy has revolutionized the treatment of certain bloo...
A new contender has emerged in the domain of pain-focused biotechnology, marking...
Denali and Sanofi have been working together since 2018, when they reached an ag...
In a chain of unfolding events reminiscent of the tumbling of dominos, Gilead Sc...
The U.S. Food and Drug Administration (FDA) has given the green light to Eohilia...
Gritstone Bio has secured a substantial sum of $433 million in federal funding e...
LianBio, a significant player in the biotech industry based in Shanghai, has rec...
CSL Behring, a prominent player in the Australian pharmaceutical landscape, rece...
In November, regulators overseeing pharmaceutical standards in the U.S. identifi...
Gilead Sciences has agreed to purchase CymaBay Therapeutics for $4.3 billion, ai...
